SCHEMBL23993147

SCHEMBL23993147

CCC(CO)Nc1ncc2ncn(C(C)C)c2n1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK2 P24941 19/20 0.58
CDK5 Q00535 15/20 0.58
DYRK1A Q13627 14/20 0.58
CCNA2 P20248 13/20 0.58
CCNA1 P78396 13/20 0.58
CDK5R1 Q15078 13/20 0.58
CDK1 P06493 7/20 0.58
CCNE1 P24864 6/20 0.58
CCNB1 P14635 5/20 0.58
CDK7 P50613 4/20 0.54
CDK9 P50750 3/20 0.54
CSNK1D P48730 2/20 0.54
CLK2 P49760 2/20 0.54
CSNK1G2 P78368 2/20 0.54
CLK4 Q9HAZ1 2/20 0.54
CSNK1G1 Q9HCP0 2/20 0.54
CCNB2 O95067 2/20 0.54
CDK4 P11802 2/20 0.54
CCND1 P24385 2/20 0.54
MAPK1 P28482 2/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23992746 0.85 CDK2 (0.47) CDK2CDK5DYRK1ACCNA2CCNA1
SCHEMBL23992749 0.85 CDK2 (0.42) CDK2CDK5DYRK1ACCNA2CCNA1
SCHEMBL18697927 0.83 CDK2 (0.48) CDK2CDK5DYRK1ACCNA2CCNA1
SCHEMBL18511090 0.78 CDK1 (0.55) CDK2CDK5DYRK1ACDK5R1CDK1
SCHEMBL16683658 0.77 CDK2 (0.45) CDK2CDK5DYRK1ACCNA2CCNA1
SCHEMBL14327305 0.77 CDK2 (0.44) CDK2CDK5DYRK1ACCNA2CCNA1
SCHEMBL19112199 0.75 CCNK (0.74) CDK2CDK5DYRK1ACCNA2CCNA1
SCHEMBL23992716 0.74 CDK2 (0.61) CDK2CDK5DYRK1ACCNA2CCNA1
SCHEMBL6747330 0.73 CDK5 (0.46) CDK2CDK5DYRK1ACCNA2CCNA1
SCHEMBL22651813 0.73 CDK5 (0.83) CDK2CDK5DYRK1ACCNA2CCNA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3901154-A1 PURINE DERIVATIVES AS DRUGS FOR THE TREATMENT OF NEONATAL HYPOXIA-ISCHEMIA BRAIN INJURY AND RELATED DISEASES Commissariat à l'énergie atomique et aux énergies alternatives (FR) 2021-10-27 EP disclosed